Epidemiologic investigations often report dose-response associations, which may be combined in metaanalyses. The authors examined how often the log odds, risk, or hazard ratio per unit increase in exposure, and its standard error, can be estimated from results reported from observational studies of diet and prostate or bladder cancer so that results are usable in meta-analyses estimating dose-response associations. Eight electronic databases were searched for studies reporting on the association of diet, nutrition, or physical activity with these cancers. A total of 767 papers reported 3,284 results; 1,999 (61%) results, reported in 545 (71%) papers, were usable in dose-response meta-analyses. The most important reason that results were not usable was the absence of sufficient information on exposure levels in the different groups. The proportion of results usable in ''high-low'' meta-analyses (comparisons of extreme categories) was similar (62%). Results that showed evidence of an association were more likely to be usable than results that found no such evidence. Insufficient detail in reporting of results of observational studies can lead to exclusion of these results from meta-analyses and is an important threat to the validity of systematic reviews of such research. Results providing evidence of associations may be overrepresented in meta-analyses of observational studies.
Systematic reviews and meta-analyses of observational studies are increasingly used to address etiologic research questions (1) . Such meta-analyses often pose challenges additional to those encountered in reviews of randomized controlled trials, since exposure effect estimates from observational studies may be affected by confounding, selection bias, and error in measurement of exposure variables (2) . The existence of a dose-response relation between exposure and outcome can help address uncertainties about misclassification effects and helps strengthen causal reasoning (3) . It is therefore desirable that meta-analyses examine the evidence for dose-response effects rather than focus solely on simple binary (''high-low'') comparisons (4) (5) (6) .
Dose-response meta-analyses typically assume a linear association between exposure and the log of the odds, risk, or rate of disease. However, the data needed to estimate such an association are often incompletely reported, which may result in exclusion of results from meta-analyses. Failure to include all available evidence will reduce precision of summary estimates and may also lead to bias if propensity to report results in sufficient detail is associated with the magnitude and/or direction of associations. We quantified the proportion of results of observational studies of the association of diet, nutrition, and physical activity with prostate or bladder cancer that can be used in meta-analyses estimating dose-response associations and examined whether there was an association between the direction and precision of the result and the probability of the result being usable for meta-analysis.
MATERIALS AND METHODS
This work was based on two of a series of systematic reviews of the association of diet with different types of cancer (7) . The statistical methods described here were developed to facilitate statistical analysis of data arising from these reviews.
We searched MEDLINE (National Library of Medicine, Bethesda, Maryland), EMBASE (Excerpta Medica Database; Elsevier, Amsterdam, the Netherlands), The Cochrane Library (The Cochrane Collaboration, Oxfordshire, United Kingdom), Pascal (Ovid Technologies, Inc., New York, New York), BIOSIS (Thomson Scientific, Stamford, Connecticut), ISI Web of Science (Thomson Scientific), LILACS (Latin American and Caribbean Health Sciences Literature; http://bvsmodelo.bvsalud.org/site/lilacs/I/ililacs.htm), and CAB Abstracts (Oxfordshire, United Kingdom; www.cabi. org/cababstracts) from inception to February 2004 for published studies that reported an association of diet, nutrition, and physical activity with the risk of cancer of the prostate or bladder. Details are available in an online supplement to this paper (posted on the Journal's website (http://aje. oupjournals.org/)). Papers were included if they reported original research: abstracts and ''gray literature'' were excluded. Here, we present results from cohort studies (including prospective and historical cohort studies, nested casecontrol and case-cohort studies) and case-control studies, which generated the majority of the data. Exposures eligible for inclusion were foods and beverages, dietary constituents, physical activity, and anthropometry. Journals were classified into three groups: epidemiology/public health, general medical (including urological), and cancer related.
We identified four types of reported associations: 1) ''dose-response'': data reported as odds, risk, or hazard ratio per unit increase in exposure, or as regression coefficients;
2) ''quantile based'': data reported as ratios comparing groups as defined by quantiles of either total numbers or numbers of controls; 3) ''categories'': data reported as ratios comparing unequal-sized groups; and 4) ''means'': data reported as means or mean differences in exposure, comparing those with and without disease. Associations may be reported in more than one of these ways in the same paper; we used one association only, in the order listed. When associations were presented with different adjustments for confounding, we extracted the ''best'' adjusted model, defined as the one that controlled for the most factors not potentially on the causal pathway from the risk factor to the disease outcome and including at least age for prostate cancer and at least smoking for bladder cancer. Unadjusted results were included only when no others were given. Because prostate and bladder cancer are relatively rare in the populations studied, the risk ratio, odds ratio, and hazard ratio are approximately equal.
For each extracted finding, we attempted to estimate the log odds, risk, or hazard ratio per unit increase in exposure (''dose-response log ratio''), together with its standard error. Table 1 summarizes the data requirements and method of estimation for each of the four types of exposure-outcome associations. When it was not possible to estimate the doseresponse log ratio, the reasons were documented.
For quantile-based or category data, the median or mean exposure in each group is required to estimate the doseresponse log ratio. When these were not reported (the majority of papers), we estimated the mean in each group on the basis of the distribution of subjects across groups (8) . For unbounded upper or lower categories, this method assumed a normal distribution of the exposure; for right-skewed distributions, the method was adapted to a lognormal distribution. When numbers of individuals per group were presented, the unadjusted log ratio was estimated by using logistic regression. For quantile-based data, if numbers of individuals were not reported, groups were assumed to be of equal sizes. We estimated the dose-response log ratio by using the method of Greenland and Longnecker (9) , which allows for correlations between ratios related to the same reference group. When a comparison of only the highest versus lowest category was possible, the dose-response log ratio was estimated from this information, provided that the mean or median exposure in each group was reported or could be calculated. Data reported as means were converted to an estimated dose-response log odds ratio by using the method of Chêne and Thompson (8) . When results were presented without confidence intervals or standard errors, the p value was used to estimate the standard error via the z or t statistic. When only an upper bound was reported (e.g., ''p < 0.05''), a conservative estimate of the standard error was calculated based on this value. If only medians were reported, they were assumed to be equal to the means. Table 2 shows the most frequently occurring problems in reporting and the solutions applied to make results usable in dose-response metaanalyses. Some studies reported results on subgroups only, for example, men and women. In this case, we estimated results for each subgroup, then derived the combined effect by using fixed-effect meta-analysis.
We also examined the number of results that were usable by comparing the highest versus the lowest category of the exposure. Results reported as comparisons of quantile-based data or categories were usable, provided that the standard error of the log ratio was reported or could be derived (from the confidence interval, p value, or v 2 statistic). To assess whether the strength of evidence or direction of the association was related to the detail in which results were reported, we categorized all results into one of five types of associations: negative, suggestive negative, no evidence, suggestive positive, and positive (for detailed definitions, refer to table 3). Categories were also defined by ignoring the direction of association (none, suggestive, strong). Ordered logistic regression was used to examine whether the strength and direction of associations were related to the probability that results were usable.
RESULTS
The prostate and bladder cancer reviews included 466 and 301 papers, respectively, published in 156 different journals (18 epidemiologic, 101 general medical, and 36 cancer related). The median year of publication was 1998. A total of 3,284 results were reported: 274 cohort studies reported 1,276 results, and 349 case-control studies reported 2,008 results. Of these, 937 (28.5 percent) results were unadjusted. The median number of results per paper was 2 (interquartile range, 1-6).
The dose-response log odds, risk, or hazard ratio and its standard error could be estimated for 1,999 (61 percent) results, reported in 545 (71 percent) papers, which were therefore usable in dose-response meta-analyses. There were 817 (66 percent) usable results from cohort studies and 1,182 (60 percent) from case-control studies. Overall, 533 (27 percent) of these results could be used without further work or assumptions. Table 4 shows the different types of work or assumptions required to estimate the dose-response log ratio in the remaining 1,466 (73 percent) usable results and the numbers of results requiring these different types of work or assumptions. Only 189 (14 percent) of 1,379 usable results from quantile-based or category data required no further work or assumptions. For all other such results (n ¼ 1,190), the mean exposure in each group was estimated by using the method of Chêne and Thompson (8) . Two hundred fifty-two results required that the standard error be estimated by using raw numbers, with 104 also requiring the odds ratio to be estimated.
Results were most commonly reported as comparisons between categories (1,362; 41 percent) or quantile-based data (1,022; 31 percent), with only 264 (8 percent) reporting dose-response associations. Five hundred sixty-nine (17 percent) reported comparisons of mean exposure, and 67 (2 percent) gave qualitative comment only. Cohort studies were (26)). Ranges were inferred from descriptions such as ''once a week,'' ''twice per month.''
Standard error was missing. The p value (either exact or the upper bound) was used to estimate the standard error.
Quantile-based data Numbers of controls (or the denominator in cohort studies) were missing.
Group sizes were assumed to be approximately equal.
Odds ratio was missing. Unadjusted odds ratios were calculated by using numbers of cases and controls in each group.
Confidence interval was missing. Standard error and hence confidence interval were calculated from raw numbers (although doing so may result in a somewhat smaller standard error than would be obtained in an adjusted analysis).
Group mean was missing. This information was estimated by using the method of Chê ne and Thompson (8) with a normal or lognormal distribution, as appropriate, or by taking midpoints (scaled in unbounded groups according to group numbers) if the number of groups was too small to calculate a distribution.
Category data Numbers of cases and controls (or the denominator in cohort studies) were missing.
These numbers were inferred based on numbers of cases and the reported odds ratio (proportions will be correct unless adjustment for confounding factors considerably altered the crude odds ratios).
How Much Observational Study Data Is Usable in Meta-Analyses? 1019 more likely than case-control studies to report dose-response data (12 percent vs. 6 percent) and less likely to report mean data (12 percent vs. 20 percent). Table 5 shows the proportions of usable results according to data and study type and the reasons that results were not usable (note that there could be more than one reason for the same result). Unsurprisingly, nearly all dose-response results were usable. For quantile-based data, 76 percent were usable, as were 44 percent for categories and 64 percent for exposure means. The most common problem was the absence of sufficient information on the range of exposure in quantilebased data and categories, followed by not reporting either numbers of individuals in exposure groups or units or frequency of measurement. Where data appeared as exposure means, the most frequent omission was a measure of precision. A total of 562 reported results were based on dichotomized exposures (e.g., ever vs. never drinking coffee). Dose-response log ratios could be derived for only 11 (2 percent) of these, primarily because the range of exposure in one or both of the groups was almost always reported too vaguely to enable the mean or median exposure to be estimated.
For 545 (71 percent) papers, a dose-response log ratio and its standard error could be estimated for at least one result. * Percentages refer to column totals. Some results required more than one type of work/assumption, so the percentages sum to more than 100. y SE, standard error. The median number of results per paper was 3 (interquartile range, 1-9) for cancer journals, 2 (interquartile range, 1-5) for epidemiology journals, and 3 (interquartile range, 1-5) for general medical journals. The median number of results in the 222 (29 percent) papers for which no dose-response log ratio could be estimated was 2 (interquartile range, 1-4). Table 6 shows the relation between the total number of reported results and the proportion of usable results in each paper. Papers reporting more than 10 results tended to have the highest proportions of usable results. Of the 32 papers reporting more than 20 results, 24 were from cancer journals, five from epidemiology journals, and three from general medical journals. The two papers reporting most results were a case-control study on diet and prostate cancer (10) (57 results, 97 percent usable) and a report of the Health Professionals Follow-up study (11) on fruit and vegetable intake and bladder cancer (46 results, 37 percent usable). Table 7 shows the proportion of usable results according to study design, journal type, and publication period, categorized as pre-1992, 1992-1997, 1998-2000, and 2001 onward. The proportions of usable results were 64 percent and 59 percent for cohort and case-control studies, respectively, and they varied from 20 percent in general medical journals in the period 1992-1997 to 78 percent in epidemiology journals in the same period. Results published in cancerrelated and epidemiology journals were more likely to be usable than results published in general medical journals. In general, the proportion of usable results was higher in more Table 9 shows representative examples of results that were usable for dose-response meta-analyses and the assumptions that were made, if needed.
Meta-analyses comparing the highest with the lowest category of exposure (high-low meta-analyses) could have included 2,032 (62 percent) of these results. Thus, there would be no substantial increase in usable results compared with a dose-response meta-analysis. In such meta-analyses, the type of data determines whether results are usable: quantilebased and category data are always usable, but doseresponse data and mean comparisons are not.
The relation of the precision and direction of results with the proportion of results that are usable is shown in table 10. When the direction of associations was taken into account (five categories of association), we found only weak evidence of association between type of association and the probability that results were usable (odds ratio per category ¼ 0.96, 95 percent confidence interval: 0.90, 1.02 for dose-response meta-analyses and odds ratio ¼ 1.05, 95 percent confidence interval: 0.99, 1.12 for high-low meta-analyses). However, when the direction of results was ignored (three categories: no, suggestive, and strong evidence), there was clear evidence that stronger associations were more likely to be usable (odds ratio per category ¼ 1.61, 95 percent confidence interval: 1.45, 1.78 for dose-response meta-analyses and odds ratio ¼ 1.92, 95 percent confidence interval: 1.73, 2.14 for high-low meta-analyses.
DISCUSSION
In a series of 767 papers providing 3,284 results on the association of food and nutrition with cancer of the prostate and the bladder, 61 percent of associations were reported in a form usable for meta-analyses estimating dose-response associations. This proportion would increase only slightly if meta-analyses were based on the highest and lowest categories of exposure. The proportion of usable results was higher in more recent publications and lower in general medical journals than in public health or cancer journals. Results that showed evidence of associations were more likely to be presented in a form usable for dose-response meta-analyses.
We conducted comprehensive literature searches, and we checked reference lists of included studies. We excluded abstracts, but results from abstracts are less likely to be usable for dose-response meta-analyses because they are reported very concisely. We did not contact authors of the papers for additional information, although doing so presumably could increase the proportion of useful results substantially. In a review of randomized trials, contacting authors resulted in usable data for 13 of 39 studies for which data were requested (12) . Papers reporting observational research often include complex analyses of associations of many exposures with multiple outcomes. Therefore, it may be more difficult to obtain additional data from authors of observational research.
We made only limited statistical assumptions to derive dose-response odds, risk, or hazard ratios usable in metaanalyses. For example, for quantile-based data, we estimated the number of controls when this information was not reported. Stronger assumptions would increase the proportion of usable results, but we judged that the decisions required would be too arbitrary. To scale log ratios to a common unit of measurement, we had to make assumptions regarding portion sizes in about 25 percent of results, which may well have introduced (random) misclassification; for example, ''serving size'' for milk will depend on whether it is consumed as a beverage or added to tea or coffee. Several authors have recommended how to report results of observational studies (13, 14) . As early as 1981, suggested guidelines for documentation of epidemiologic studies were published (15) . However, they focused on design and data analysis and made few recommendations on how to present results. More recently, two studies have focused on the quality of reporting of observational studies. Tooth et al. (16) found that, on average, 17 of the 33 criteria related to the validity of observational research were reported, and they suggest that a structured approach to presenting results from such studies is required. Pocock et al. (17) expressed concerns regarding inadequacies in the analysis and reporting of epidemiologic research based on a survey of published studies in high-impact epidemiologic and general medical journals. Although these papers did not assess whether published results were usable for meta-analysis, their findings that reporting of observational studies needs to be improved are consistent with the results presented here.
Other authors have considered difficulties in extracting data for meta-analysis of different types of studies. Chan et al. (18) reported data required for meta-analyses of randomized controlled trials, whereas Riley et al. (19) focused on prognostic studies. Consistent with the findings reported here, Chan et al. (18) found that the odds of an outcome being reported were more than doubled if the treatment effect for an outcome was statistically significant. Selective reporting of outcomes thus has the potential to cause serious bias in meta-analyses of randomized controlled trials.
The majority of usable results in our study (n ¼ 2,384; 74 percent) were reported as odds, risk, or hazard ratios comparing one or more exposure categories with a baseline category. Reporting results in this way has advantages: the reader can check informally for nonlinear exposure effects, and the magnitude of the association is readily interpretable. However, estimates of the dose-response association derived from categorized exposure data are dependent on the exposure value assigned to each category. Il'yasova et al. (20) found that use of midrange scores for the exposure level in each category led to reasonably good approximations to the (21) used simulation studies to examine the bias in dose-response estimates that can result from exposure categorization, which they found to be greater when the exposure distribution was nonnormal or when categories were defined by quintiles rather than deciles of the exposure distribution. These issues may imply that authors should publish direct estimates of the dose-response association as well as results based on exposure categories.
One of the most important reasons that a dose-response odds, risk, or hazard ratio could not be estimated was that the range of the exposure, or for dose-response data the unit of increase, was not reported (82 percent of nonusable results). For example, an odds ratio comparing seven or fewer versus more than seven glasses of beer weekly cannot be used because mean consumption in one of the groups cannot be estimated. We hope that this paper will help alert authors and editors to the improved reporting of epidemiologic associations needed to facilitate the conduct of dose-response meta-analyses. Guidelines on how to report observational studies, the STROBE statement (22) , explicitly recommend reporting this information and may also be expected to improve matters in this regard. It would be desirable for journals publishing observational studies to amend their editorial guidelines in light of the STROBE statement to encourage adequate reporting.
Meta-analyses based on ''high versus low'' category comparisons are commonly used to summarize results of observational studies (e.g., Etminan et al. (23) , Gao et al. (24) ). However, results of such meta-analyses can be difficult to interpret because the exposure ranges compared will typically vary substantially between studies and will often be unknown. The results presented here suggest that doseresponse meta-analyses are an attractive alternative. A similar proportion of results are usable in meta-analyses, and standardization of the scale of the exposure means that the pooled estimate has a direct biologic interpretation. Doseresponse meta-analyses will be misleading when associations are clearly nonlinear (e.g., the association between alcohol consumption and risk of coronary heart disease). Therefore, linearity assumption should be checked for each study, before dose-response meta-analyses are conducted.
Although more recently published results were more likely to be usable in dose-response meta-analyses, 28 percent of results published since 2001 were not. Contacting authors might alleviate this problem but involves substantial extra work by reviewers. Results of observational studies should be presented with a description of the unit and range of exposure and numbers in each category, and odds, risk, or hazard ratios should be given with confidence intervals. Table 11 presents the information required for data to be usable for dose-response meta-analysis for each type of result. Addressing problems such as the omission of ranges or numbers of individuals would require at most minor increases in the space required for tables of results. Furthermore, the increasing use of Web appendices and online publication means that space constraints should not be seen as an obstacle to complete reporting. Since, currently, a substantial proportion of results are likely to be excluded from meta-analyses of observational research, reviews of such research should clearly state the numbers of results that were and were not included in meta-analyses, describe results that were not included, and discuss the likely direction of biases resulting from omission of incomplete reporting.
